Long-term survival in an advanced gastric cancer patient treated with cetuximab in association with FOLFIRI: a case report

In December 2004, a 52-year-old woman with metastatic gastric cancer was enrolled in the phase II clinical trial FOLCETUX, receiving cetuximab at an initial dose of 400 mg/m(2) i.v. followed by weekly doses of 250 mg/m(2), irinotecan 180 mg/m(2) i.v. on day 1, LFA 100 mg/m(2) i.v. followed by 5-FU 4...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Adua, Daniela, Di Fabio, Francesca, Rojas Llimpe, Fabiola Lorena, Pini, Sara, Pinto, Carmine
Format: Artigo
Sprog:Inglês
Udgivet: Pioneer Bioscience Publishing Company 2014
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3904018/
https://ncbi.nlm.nih.gov/pubmed/24490046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2013.046
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker